Who has invested in Onxeo?

Capital Ventures, Nyenburgh are named among the investors backing Onxeo.

Onxeo Funding: $14M Raised, Series B (2016)

Onxeo funding overview

Onxeo is based in Paris, France. Onxeo has raised $14M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series B announced in September 2016. The round record for Onxeo runs through 2016; nothing later has been disclosed. Investors on record include Capital Ventures, Nyenburgh. 2 distinct backers are named across the disclosed rounds.

Onxeo at a glance

Total raised: $14M
Latest round: Series B
Latest round date: September 2016
Headquarters: Paris, France
Notable investors: Capital Ventures, Nyenburgh

Frequently asked about Onxeo funding

How much has Onxeo raised?: Onxeo has raised $14M in total disclosed funding across the rounds on record.
Who has invested in Onxeo?: Capital Ventures, Nyenburgh are named among the investors backing Onxeo.
What was the latest Onxeo funding round?: The most recent disclosed round is a Series B, announced in September 2016.
Where is Onxeo based?: Onxeo is based in Paris, France.
When did Onxeo last raise?: The last disclosed Onxeo round closed in September 2016 at Series B.

We update the Onxeo record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Paris and their backers are listed below.

Onxeo Funding: $14M Raised, Series B (2016)

Onxeo funding overview

Onxeo at a glance

Frequently asked about Onxeo funding

Companies related to Onxeo (19)

Browse related funding lists (5)